O2 Concepts, LLC

O2 Concepts manufactures portable oxygen concentrators (POCs) for home and ambulatory use. The company's primary product line includes the Oxlife LIBERTY2® and Oxlife INDEPENDENCE® POCs, which deliver continuous-flow and pulse-mode oxygen therapy at varying output rates (2.0 LPM and 3.0 LPM respectively). The LIBERTY2® features 10 pulse settings and 2.0 LPM continuous flow capability; the INDEPENDENCE® offers 12 pulse settings and 3.0 LPM continuous flow, marketed for long-term reliability and durability. O2 Concepts also provides DNA Technology®, a proprietary remote monitoring platform enabling device-initiated clinical and asset monitoring for durable medical equipment (DME) providers and respiratory care suppliers. This connected-device capability allows providers to track patient adherence and equipment performance in real time. The company serves DME suppliers, home healthcare providers, and respiratory care specialists across North America. Products are designed for patients requiring supplemental oxygen therapy in home, portable, and institutional settings. O2 Concepts positions itself as offering industry-leading customer service, technical support, and comprehensive partnership with healthcare providers. No specific FDA, ISO, or regulatory certifications are explicitly mentioned on the fetched content.